It has been demonstrated that depletion of NLRP3 could significantly suppress amyloidosis and neuropathology, as well as improve cognitive function in AD mice [35], indicating that the NLRP3 inflammasome is a possible molecular target for neuroprotection and therapeutic intervention in AD. The gene discussed is NLRP3; the disease is amyloidosis.